Michael Lowry
Assistant Professor
Also affiliated: Intermountain Healthcare (2003); University of Iowa (1977–2008); Ames Research Center (1992–2023); SRI International (1982); United States Department of Veterans Affairs (1979); Jet Propulsion Laboratory (1998); Trout Unlimited (2004); Research Institute for Advanced Computer Science (2005); University of Utah (1980–2005); NASA Research Park (2018); New South Wales Department of Primary Industries (2011); University of Iowa Hospitals and Clinics (1984); Miami-Dade Public Library System (2025); Thomas Jefferson National Accelerator Facility (2013–2016); Children's of Alabama (1981); Menlo School (1982); Birmingham Children's Hospital (1981); Stinger Ghaffarian Technologies (United States) (2016); University of the West Indies (1979); AM Technologies (Poland) (1994); Johnson Space Center (2011); Kestrel Institute (1988–2003); Kestrel Technology (United States) (2005); College of New Jersey (2002); Virginia Tech (2023–2025); Stanford University (1981–1987)
Faculty Researcher
Internal Medicine, College of Medicine
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Michael Lowry's research focuses on understanding and addressing health disparities, particularly within the context of chronic kidney disease and hemodialysis. His work investigates the prevalence and impact of depressive disorders among adult patients undergoing home hemodialysis, aiming to identify factors that contribute to mental health challenges in this population. He has explored the relationship between medical treatments and patient outcomes, with a specific interest in how various interventions affect the quality of life and mental well-being of individuals with chronic health conditions.
Lowry's academic profile includes a strong publication record, with 119 total publications and an h-index of 23, indicating a significant contribution to his field. He has received recognition as a highly cited researcher. His collaborations at the University of Arkansas for Medical Sciences with Keyur S. Vyas, J. Curran Henson, Jordan Myers, and Megan A. Cummins further highlight his engagement within the research community. Lowry maintains an active lab website, suggesting an ongoing commitment to research and the dissemination of findings.
Metrics
- h-index: 23
- Publications: 118
- Citations: 2,124
Selected Publications
-
Atypical Case of Takayasu Aortitis Presenting as Embolic Stroke With Concomitant Massive Thoracic Artery Aneurysm (2026)
-
A case of primary intraocular B-cell lymphoma masquerading alongside varicella-zoster virus retinitis (2025)
-
Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i> (2024)
-
Image Diagnosis: Aortic Thrombus in Severe Hypercortisolemia (2018)
Collaboration Network
Top Collaborators
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- A case of primary intraocular B-cell lymphoma masquerading alongside varicella-zoster virus retinitis
- A case of primary intraocular B-cell lymphoma masquerading alongside varicella-zoster virus retinitis
- A case of primary intraocular B-cell lymphoma masquerading alongside varicella-zoster virus retinitis
- A case of primary intraocular B-cell lymphoma masquerading alongside varicella-zoster virus retinitis
- A case of primary intraocular B-cell lymphoma masquerading alongside varicella-zoster virus retinitis
- A case of primary intraocular B-cell lymphoma masquerading alongside varicella-zoster virus retinitis
- Atypical Case of Takayasu Aortitis Presenting as Embolic Stroke with Concomitant Massive Thoracic Artery Aneurysm
Similar Researchers
Based on overlapping research topics